Huafeng Kang
Publication Activity (10 Years)
Years Active: 2019-2024
Publications (10 Years): 6
Publications (10 Years): 6
Publications
- Peng Xu, Wen Luo, Jingjing Hu, Xiaobin Ma, Qian Hao, Wentao Hui, Zhangjian Zhou, Shuai Lin, Meng Wang, Hao Wu, Zhi-Jun Dai, Huafeng Kang
- Lidan Chang, Dandan Liu, Xuyan Zhao, Luyao Dai, Xueting Ren, Qian Hao, Peinan Liu, Hao Wu, Xiaobin Ma, Huafeng KangCan neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
- Lidan Chang, Dandan Liu, Xuyan Zhao, Luyao Dai, Xueting Ren, Qian Hao, Peinan Liu, Hao Wu, Xiaobin Ma, Huafeng KangCan neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (9) (2024)
- Peng Xu, Wen Luo, Jingjing Hu, Xiaobin Ma, Qian Hao, Wentao Hui, Zhangjian Zhou, Shuai Lin, Meng Wang, Hao Wu, Zhi-Jun Dai, Huafeng Kang
- Shuai Lin, Qianwen Sheng, Xiaobin Ma, Shanli Li, Peng Xu, Cong Dai, Meng Wang, Huafeng Kang, Zhi-Jun Dai
- Xiaobin Ma, Chengxue Dang, Weili Min, Yan Diao, Wentao Hui, Xiaolong Wang, Zhijun Dai, Xijing Wang, Huafeng Kang